Ocugen (OCGN) Total Debt Growth (3y) (2017 - 2026)
Ocugen (OCGN) Total Debt Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 50.25% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 25.25% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | 132.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.80% |
| Dec 31, 2025 | 132.56% |
| Sep 30, 2025 | 132.32% |
| Jun 30, 2025 | 152.06% |
| Mar 31, 2025 | 151.90% |
| Dec 31, 2024 | 155.85% |
| Sep 30, 2024 | 19.47% |
| Jun 30, 2024 | 19.52% |
| Mar 31, 2024 | 4.91% |
| Dec 31, 2023 | 10.83% |
| Sep 30, 2023 | -4.23% |
| Jun 30, 2023 | -23.38% |
| Mar 31, 2023 | 13.55% |
| Dec 31, 2022 | 28.77% |
| Sep 30, 2022 | 28.87% |
| Jun 30, 2022 | -31.72% |
| Mar 31, 2022 | 15.45% |
| Dec 31, 2021 | -39.20% |
| Sep 30, 2021 | -17.73% |
| Jun 30, 2021 | 83.08% |